(4S)-GLP-1 receptor agonist 14 is a potent and orally active GLP-1 receptor agonist with an EC50 ≤ 20 nM. It can be used for research on diabetes, obesity, metabolic diseases, cardiovascular diseases, liver diseases, nonalcoholic steatohepatitis (NASH), and other diseases associated with the GLP-1 receptor.
- Potent and orally active GLP-1 receptor agonist
- EC50 ≤ 20 nM
- Applicable for research on various diseases including diabetes, obesity, metabolic diseases, cardiovascular diseases, liver diseases, and nonalcoholic steatohepatitis (NASH)